Copyright
©The Author(s) 2021.
World J Clin Cases. Jan 6, 2021; 9(1): 163-169
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.163
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.163
Clinical values (normal range) | |
WBC (/μL) | 6800 (4000-9600) |
Hb (g/dL) | 14.7 (13.2-17.3) |
Platelets × 104 (/μL) | 21.9 (16-35) |
Total protein (g/dL) | 7.3 (6.3-7.9) |
Albumin (g/dL) | 3.7 (3.9-5.0) |
Total bilirubin (mg/dL) | 0.6 (0.3-1.2) |
AST (U/L) | 18 (13-33) |
ALT (U/L) | 10 (8-42) |
LDH (U/L) | 221 (119-229) |
ALP (U/L) | 229 (115-359) |
γ-GTP (U/L) | 16 (10-47) |
ChE (U/L) | 257 (213-501) |
AMY (U/L) | 78 (49-136) |
Blood urea nitrogen (mg/dL) | 5 (8-20) |
Creatinine (mg/dL) | 0.60 (0.65-1.07) |
Na (mEq/L) | 144 (137-145) |
K (mEq/L) | 4.0 (3.5-4.8) |
Cl (mEq/L) | 107 (100-107) |
T-Cho (mg/dL) | 206 (128-219) |
TG (mg/dL) | 44 (30-149) |
HbA1c (%) | 5.4 (4.6-6.2) |
Glycoalbumin (%) | 15.8 (11.0-16.0) |
Insulin antibody | Negative |
CEA (ng/mL) | 2.2 (0-5.0) |
SCC (ng/mL) | 1.0 (0-1.5) |
NSE (ng/mL) | 10.6 (0-12) |
CYFRA (ng/mL) | 2.1 (< 3.5) |
ProGRP (pg/mL) | 51.8 (< 80) |
SLX (U/mL) | 19.4 (0-38.0) |
Blood glucose (mg/dL) | 130 (80-110) |
Immunoreactive insulin (μg/mL) | 6.8 (1.0-21.74) |
Serum C-peptide (ng/mL) | 1.50 (1.1-3.3) |
Free T3 (pg/mL) | 2.30 (1.88-3.18) |
Free T4 (ng/dL) | 0.93 (0.70-1.48) |
Adrenocorticotropic hormone (pg/mL) | 77.0 (7.2-63.3) |
Cortisol (μg/dL) | 11.0 (3.0-19.6) |
Human growth hormone (ng/mL) | < 0.07 (< 2.10) |
IGF-1 (ng/mL) | 92 |
- Citation: Matsumoto S, Yamada E, Nakajima Y, Yamaguchi N, Okamura T, Yajima T, Yoshino S, Horiguchi K, Ishida E, Yoshikawa M, Nagaoka J, Sekiguchi S, Sue M, Okada S, Fukuda I, Shirabe K, Yamada M. Late-onset non-islet cell tumor hypoglycemia: A case report. World J Clin Cases 2021; 9(1): 163-169
- URL: https://www.wjgnet.com/2307-8960/full/v9/i1/163.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i1.163